2025 mavacamten import price list

Mavacamten (mavacamten) is a new treatment for obstructive hypertrophic cardiomyopathy (HCM). Hypertrophic cardiomyopathy is a hereditary heart disease characterized by abnormal thickening of the heart muscle, resulting in limited cardiac function, especially affecting the heart's ability to relax and pump blood. For many patients, the condition not only causes a range of heart-related symptoms, such as shortness of breath, chest pain, and fatigue, but can also lead to serious complications, such as heart failure or arrhythmias.

Mavacate improves the patient's cardiac function and overall symptoms by selectively inhibiting troponin in the myocardium and regulating the heart's ability to contract and relax. This mechanism allows Mavaceta to effectively reduce blood flow obstruction caused by myocardial thickening and help patients restore normal exercise ability and quality of life.

Clinical studies have shown that Mavakatai has a significant effect on patients with New York Heart Association (NYHA) grade II-III HCM, helping them improve symptoms in daily life and improve their physical functional status. This provides a new treatment option for many patients facing the challenges of obstructive hypertrophic cardiomyopathy and marks an important advance in the treatment of heart disease. With this drug, patients can expect better disease management and quality of life

Currently, Mavakatai’s original drug has been launched in China and is included in the scope of medical insurance. The main specifications are2.5mg*14 capsules*2 boards, 5mg*14 capsules*2 boards, 10mg*14 capsules*2 boards, and 15mg*14 capsules*2 boards. However, due to the short time the drug has been on the market, the specific price has not yet been determined. In the international market, Mavakatai’s original drug is available in European and American versions. The American version of 2.5 mg is priced at approximately RMB 60,000, and the European version of 5 mg is priced at approximately RMB 20,000 (affected by exchange rate fluctuations). At the same time, overseas markets also provide generic drugs of Mavakatai. The ingredients are basically the same as the original drugs, and the price is about 1,050 yuan (also affected by the exchange rate).

Reference materials:https://en.wikipedia.org/wiki/Mavacamten